These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2449181)

  • 1. Purified L-type calcium channels: only one single polypeptide (alpha 1-subunit) carries the drug receptor domains and is regulated by protein kinases.
    Glossmann H; Striessnig J; Hymel L; Schindler H
    Biomed Biochim Acta; 1987; 46(8-9):S351-6. PubMed ID: 2449181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the drug receptors of the purified skeletal muscle calcium channel.
    Striessnig J; Glossmann H
    Prog Clin Biol Res; 1988; 252():35-40. PubMed ID: 2450374
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction between calcium channel ligands and calcium channels.
    Glossmann H; Striessnig J; Ferry DR; Goll A; Moosburger K; Schirmer M
    Circ Res; 1987 Oct; 61(4 Pt 2):I30-6. PubMed ID: 2443273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
    Glossmann H; Ferry DR; Goll A; Rombusch M
    J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purified dihydropyridine-binding site from skeletal muscle t-tubules is a functional calcium channel.
    Flockerzi V; Oeken HJ; Hofmann F; Pelzer D; Cavalié A; Trautwein W
    Nature; 1986 Sep 4-10; 323(6083):66-8. PubMed ID: 2427959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channels: basic properties as revealed by radioligand binding studies.
    Glossmann H; Ferry DR; Goll A; Striessnig J; Schober M
    J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S20-30. PubMed ID: 2414589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel.
    Striessnig J; Knaus HG; Grabner M; Moosburger K; Seitz W; Lietz H; Glossmann H
    FEBS Lett; 1987 Feb; 212(2):247-53. PubMed ID: 2434359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subunit composition is a major determinant in high affinity binding of a Ca2+ channel blocker.
    Suh-Kim H; Wei X; Birnbaumer L
    Mol Pharmacol; 1996 Nov; 50(5):1330-7. PubMed ID: 8913365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel.
    Striessnig J; Knaus HG; Glossmann H
    Biochem J; 1988 Jul; 253(1):39-47. PubMed ID: 2844171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations.
    Vaghy PL; Striessnig J; Miwa K; Knaus HG; Itagaki K; McKenna E; Glossmann H; Schwartz A
    J Biol Chem; 1987 Oct; 262(29):14337-42. PubMed ID: 2443504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic morphine treatment decreases the Cav1.3 subunit of the L-type calcium channel.
    Haller VL; Bernstein MA; Welch SP
    Eur J Pharmacol; 2008 Jan; 578(2-3):101-7. PubMed ID: 18048029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reconstitution of the purified receptor for calcium channel blockers.
    Sieber M; Nastainczyk W; Röhrkasten A; Hofmann F
    Biomed Biochim Acta; 1987; 46(8-9):S357-62. PubMed ID: 2829861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific phosphorylation of a site in the full-length form of the alpha 1 subunit of the cardiac L-type calcium channel by adenosine 3',5'-cyclic monophosphate-dependent protein kinase.
    De Jongh KS; Murphy BJ; Colvin AA; Hell JW; Takahashi M; Catterall WA
    Biochemistry; 1996 Aug; 35(32):10392-402. PubMed ID: 8756695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits.
    Mitterdorfer J; Froschmayr M; Grabner M; Moebius FF; Glossmann H; Striessnig J
    Biochemistry; 1996 Jul; 35(29):9400-6. PubMed ID: 8755718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the sites phosphorylated by cyclic AMP-dependent protein kinase on the beta 2 subunit of L-type voltage-dependent calcium channels.
    Gerhardstein BL; Puri TS; Chien AJ; Hosey MM
    Biochemistry; 1999 Aug; 38(32):10361-70. PubMed ID: 10441130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular properties of brain sodium channels: an important target for anticonvulsant drugs.
    Catterall WA
    Adv Neurol; 1999; 79():441-56. PubMed ID: 10514834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of the calcium antagonist receptor of the voltage-sensitive calcium channel by cAMP-dependent protein kinase.
    Curtis BM; Catterall WA
    Proc Natl Acad Sci U S A; 1985 Apr; 82(8):2528-32. PubMed ID: 2581248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The alpha 1-subunit of skeletal muscle L-type Ca channels is the key target for regulation by A-kinase and protein phosphatase-1C.
    Zhao XL; Gutierrez LM; Chang CF; Hosey MM
    Biochem Biophys Res Commun; 1994 Jan; 198(1):166-73. PubMed ID: 8292020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel.
    Striessnig J; Moosburger K; Goll A; Ferry DR; Glossmann H
    Eur J Biochem; 1986 Dec; 161(3):603-9. PubMed ID: 2431906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SR33557, an indolizinsulfone blocker of Ca2+ channels: identification of receptor sites and analysis of its mode of action.
    Schmid A; Romey G; Barhanin J; Lazdunski M
    Mol Pharmacol; 1989 Jun; 35(6):766-73. PubMed ID: 2543910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.